Medicinal chemistry of histamine H3 receptor agonists

Pharmacochemistry Library

Volumn 30, Issue C, 1998, Pages 175-196

  Krause, M ^a   Stark, H ^a   Schunack, W ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345150678     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(98)80030-5     Document Type: Article

References (50)

1. Arrang J.-M., Garbarg M., and Schwartz J.-C. Nature (London) 102 (1983) 832
2. Arrang J.-M., Garbarg M., and Schwartz J.-C. Neuroscience 23 (1987) 149
3. Burgaud J.L., and Oudart N. J. Pharm. Pharmacol. 45 (1993) 955
4. Schlicker E., Malinowska B., Kathmann M., and Göthert M. Fundam. Clin. Pharmacol. 8 (1994) 128
5. 3 Receptor as Target for New Drugs (1998), Elsevier Science Publishers B. V., Amsterdam
6. Rouleau A., Garbarg M., Ligneau X., Mantion C., Lavie P., Advenier C., Lecomte J.-M., Krause M., Stark H., Schunack W., and Schwartz J.-C. J. Pharmacol. Exp. Ther. 281 (1997) 1085
7. Leurs R., Vollinga R.C., and Timmerman H. In: Jucker B. (Ed). Progress in Drug Research (1992), Birkhäuser Verlag, Basel 127-165
8. Lipp R., Stark H., and Schunack W. In: Schwartz J.-C., and Haas H.L. (Eds). The Histamine Receptor, Receptor Biochemistry and Methodology (1992), Wiley Liss, Inc., New York 57-72
9. Arrang J.-M., Garbarg M., Quach T.T., Dam Trung Tuong M., Yeramian E., and Schwartz J.-C. Eur. J. Pharmacol. 111 (1985) 73
10. Kathmann M., Schlicker E., and Göthert M. Psychopharmacology 116 (1994) 464
11. Gobbi S., Menge W., and Timmerman H. Poster presented at the 11th Noordwijkerhout-Camerino Symposium. Noordwijkerhout, The Netherlands (1997)
12. C. R. Ganellin, personal communication.
13. Cooper D.G., Young R.C., Durant G.J., and Ganellin C.R. In: Hansch C. (Ed). Comprehensive Medicinal Chemistry: the Rational Design, Mechanistic Study & Therapeutic Application of Chemical Compounds (1990), Pergamon Press, Oxford, U.K. 323-421
14. Schwartz J.-C., Arrang J.-M., Garbarg M., and Schunack W. In: Harms A.F. (Ed). Innovative Approaches in Drug Research (1986), Elsevier Science Publishers B. V., Amsterdam 73-89
15. Arrang J.-M., Garbarg M., Lancelot J.-C., Lecomte J.-M., Pollard H., Robba M., Schunack W., and Schwartz J.-C. Nature (London) 327 (1987) 117
16. Gerhard G., and Schunack W. Arch. Pharm. (Weinheim) 313 (1980) 709
17. Lipp R., Arrang J.-M., Garbarg M., Luger P., Schwartz J.-C., and Schunack W. J. Med. Chem. 35 (1992) 4434
18. Friary R.J., Mangiaracina P., Nafissi M., Orlando S.O., Rosenhouse S., Seidl V.A., and Shih N.-Y. Tetrahedron 49 (1993) 1993
19. Arrang J.-M., Schwartz J.-C., and Schunack W. Eur. J. Med. Pharmacol. 117 (1985) 109
20. Lipp R., Stark H., Arrang J.-M., Garbarg M., Schwartz J.-C., and Schunack W. Eur. J. Med. Chem. 30 (1995) 219
21. J.-M. Arrang, M. Garbarg, W. Schunack, J.-C. Schwartz and R. O. Lipp, European Patent Application 0 214 058 (1987).
22. Shih N.-Y., Lupo A.T., Aslanian R., Orlando S., Piwinski J.J., Green M.J., Ganguly A.K., Clark M.A., Tozzi S., Kreutner W., and Hey J.A. J. Med. Chem. 38 (1995) 1593
23. Shih N.-Y., Aslanian R., Lupo A.T., Duguma L., Orlando S., Piwinski J.J., Green M.J., Ganguly A.K., Clark M., Tozzi S., Kreutner W., and Hey J.A. Poster presented at New Perspectives in Histamine Research. Winnipeg, Manitoba, Canada (1994)
24. de Esch I.J.P., Menge W.M.P.B., Nederkorn P.H.J., and Timmerman H. Poster presented at the 11th Noordwijkerhout-Camerino Symposium. Noordwijkerhout, The Netherlands (1997)
25. M. A. Khan, S. L. Yates, C. E. Tedford, K. Kirschbaum and J. G. Phillips, submitted.
26. Hough L.B., Khandelwal J.K., and Mittag T.W. Agents Actions 11 (1981) 425
27. van der Goot H., Schepers M.J.P., Sterk G.J., and Timmerman H. Eur. J. Med. Chem. 27 (1992) 511
28. Howson W., Parsons M.E., Raval P., and Swayne G.T.G. Bioorg. Med. Chem. Lett. 2 (1992) 77
29. Ganellin C.R., Bang-Andersen B., Khalaf Y.S., Tertiuk W., Arrang J.-M., Garbarg M., Ligneau X., Rouleau A., and Schwartz J.-C. Bioorg. Med. Chem. Lett. 2 (1992) 1231
30. Vollinga R.C., Menge W.M.P.B., Leurs R., and Timmerman H. J. Med. Chem. 38 (1995) 266
31. PCT Int. Patent Appl. WO 93/12108. Shih N.-Y., Aslanian R., Lupo A., Piwinski J.J., Green M.J., and Ganguly A.K. Imidazolyl or Imidazolylalkyl Substituted with a Four or Five Membered Nitrogen Containing Heterocyclic Ring (1993)
32. PCT Int. Patent Appl. WO 93/12107. Shih N.-Y., and Green M.J. Imidazolylalkyl Substituted with a Six Membered Nitrogen Containing Heterocyclic Ring (1993)
33. Vollinga R.C., de Koning J.P., Jansen F.P., Leurs R., Menge W.M.P.B., and Timmerman H. J. Med. Chem. 37 (1994) 332
34. 3 Agonists/Antagonists (1993)
35. Sippl W., Stark H., and Höltje H.-D. Quant. Struct.-Act. Relat. 14 (1995) 121
36. Leurs R., Kathmann M., Vollinga R.C., Menge W.M.P.B., Schlicker E., and Timmerman H. J. Pharmacol. Exp. Ther. 276 (1996) 1009
37. Schlicker E., Kathmann M., Bitschnau H., Marr I., Reidemeister S., Stark H., and Schunack W. Naunyn-Schmiedeberg's Arch. Pharmacol. 353 (1996) 482
38. Watt G.F., Sykes D.A., Roberts S.P., Shankley N.P., and Black J.W. Poster presented at the Meeting of the British Pharmacological Society. Edinburgh, UK (1997)
39. J.-C. Schwartz, J.-M. Arrang, M. Garbarg, A. Quemener, J.-M. Lecomte, X. Ligneau, W. G. Schunack, H. Stark, K. Purand, A. Hüls, S. Reidemeister, S. Athmani, C. R. Ganellin, N. Pelloux-Leon and W. Tertiuk, FR Patent FR 2 732 017-A1 (1995).
40. Arrang J.-M., Garbarg M., Schwartz J.-C., Lipp R., Stark H., Schunack W., and Lecomte J.-M. Agents Actions, Suppl. 33 (1991) 55
41. Ligneau X., Garbarg M., Vizuete M.L., Diaz J., Purand K., Stark H., Schunack W., and Schwartz J.-C. J. Pharmacol. Exp. Ther. 271 (1994) 452
42. Yamazaki S., Sakurai E., Hikichi N., Sakai N., Maeyama K., and Watanabe T. J. Pharm. Pharmacol. 46 (1994) 371
43. Schwartz J.-C., Pollard H., Bischoff S., Rehault M.C., and Verdière-Sahuque M. Eur. J. Pharmacol. 16 (1971) 326
44. Krause M., Rouleau A., Stark H., Luger P., Lipp R., Garbarg M., Schwartz J.-C., and Schunack W. J. Med. Chem. 38 (1995) 4070
45. Krause M., Rouleau A., Stark H., Luger P., Garbarg M., Schwartz J.-C., and Schunack W. Arch. Pharm. Pharm. Med. Chem. 329 (1996) 209
46. Krause M., Rouleau A., Stark H., Garbarg M., Schwartz J.-C., and Schunack W. Pharmazie 51 (1996) 720
47. Morini G., Grandi D., and Bertaccini G. Digestion 56 (1995) 145
48. Morini G., Grandi D., Krause M., and Schunack W. Inflamm. Res. 46 Suppl. 1 (1997) S101
49. Belcheva M., Marazova K., Lozeva V., and Schunack W. Inflamm. Res. 46 Suppl. 1 (1997) S113
50. Krause M., Rouleau A., Stark H., Garbarg M., Schwartz J.-C., and Schunack W. Sci. Pharm. 64 (1996) 503